Literature DB >> 26151486

Histone deacetylases: Targets for antifungal drug development.

Livia Kmetzsch1,2.   

Abstract

The interaction of pathogens and its hosts causes a drastic change in the transcriptional landscape in both cells. Among the several mechanisms of gene regulation, transcriptional initiation is probably the main point. In such scenario, the access of transcriptional machinery to promoter is highly regulated by post-translational modification of histones, such as acetylation, phosphorylation and others. Inhibition of histone deacetylases is able to reduce fungal pathogens fitness during infection and, therefore, is currently being considered for the development of new antifungal therapy strategies.

Entities:  

Keywords:  Cryptococcus neoformans; fungal pathogens; histone deacetylases; histone deacetylases inhibitors; sodium butyrate; trichostatin A

Mesh:

Substances:

Year:  2015        PMID: 26151486      PMCID: PMC4720245          DOI: 10.1080/21505594.2015.1049807

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  20 in total

1.  The Rpd3/Hda1 family of histone deacetylases regulates azole resistance in Candida albicans.

Authors:  Xiaofang Li; Qing Cai; Huan Mei; Xiaowei Zhou; Yongnian Shen; Dongmei Li; Weida Liu
Journal:  J Antimicrob Chemother       Date:  2015-03-29       Impact factor: 5.790

2.  Histone deacetylases inhibitors effects on Cryptococcus neoformans major virulence phenotypes.

Authors:  Fabiana As Brandão; Lorena S Derengowski; Patrícia Albuquerque; André M Nicola; Ildinete Silva-Pereira; Marcio J Poças-Fonseca
Journal:  Virulence       Date:  2015-06-23       Impact factor: 5.882

3.  Sodium butyrate inhibits pathogenic yeast growth and enhances the functions of macrophages.

Authors:  Long Nam Nguyen; Livia Cristina Liporagi Lopes; Radames J B Cordero; Joshua D Nosanchuk
Journal:  J Antimicrob Chemother       Date:  2011-09-12       Impact factor: 5.790

4.  Identification of a key lysine residue in heat shock protein 90 required for azole and echinocandin resistance in Aspergillus fumigatus.

Authors:  Frédéric Lamoth; Praveen R Juvvadi; Erik J Soderblom; M Arthur Moseley; Yohannes G Asfaw; William J Steinbach
Journal:  Antimicrob Agents Chemother       Date:  2014-01-06       Impact factor: 5.191

Review 5.  Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS.

Authors:  Benjamin J Park; Kathleen A Wannemuehler; Barbara J Marston; Nelesh Govender; Peter G Pappas; Tom M Chiller
Journal:  AIDS       Date:  2009-02-20       Impact factor: 4.177

6.  The Set3/Hos2 histone deacetylase complex attenuates cAMP/PKA signaling to regulate morphogenesis and virulence of Candida albicans.

Authors:  Denes Hnisz; Olivia Majer; Ingrid E Frohner; Vukoslav Komnenovic; Karl Kuchler
Journal:  PLoS Pathog       Date:  2010-05-13       Impact factor: 6.823

7.  Histone deacetylase inhibitors may reduce pathogenicity and virulence in Candida albicans.

Authors:  Giovanna Simonetti; Claudio Passariello; Dante Rotili; Antonello Mai; Enrico Garaci; Anna Teresa Palamara
Journal:  FEMS Yeast Res       Date:  2007-07-12       Impact factor: 2.796

8.  Activity of MGCD290, a Hos2 histone deacetylase inhibitor, in combination with azole antifungals against opportunistic fungal pathogens.

Authors:  M A Pfaller; S A Messer; N Georgopapadakou; L A Martell; J M Besterman; D J Diekema
Journal:  J Clin Microbiol       Date:  2009-09-30       Impact factor: 5.948

9.  Azole resistance in Cryptococcus gattii from the Pacific Northwest: Investigation of the role of ERG11.

Authors:  Charles E Gast; Luiz R Basso; Igor Bruzual; Brian Wong
Journal:  Antimicrob Agents Chemother       Date:  2013-08-26       Impact factor: 5.191

10.  Histone deacetylase inhibition as an alternative strategy against invasive aspergillosis.

Authors:  Frédéric Lamoth; Praveen R Juvvadi; William J Steinbach
Journal:  Front Microbiol       Date:  2015-02-16       Impact factor: 5.640

View more
  3 in total

1.  Fungal acetylome comparative analysis identifies an essential role of acetylation in human fungal pathogen virulence.

Authors:  Yanjian Li; Hailong Li; Mingfei Sui; Minghui Li; Jiamei Wang; Yang Meng; Tianshu Sun; Qiaojing Liang; Chenhao Suo; Xindi Gao; Chao Li; Zhuoran Li; Wei Du; Baihua Zhang; Sixiang Sai; Zhang Zhang; Jing Ye; Hongchen Wang; Shang Yue; Jiayi Li; Manli Zhong; Changbin Chen; Shouliang Qi; Ling Lu; Dancheng Li; Chen Ding
Journal:  Commun Biol       Date:  2019-05-01

2.  Histone deacetylase inhibitor attenuates experimental fungal keratitis in mice.

Authors:  Xiaohua Li; Min Yuan; Ruijie Yin; Xiaohui Liu; Yu Zhang; Shengtao Sun; Lei Han; Shikun He
Journal:  Sci Rep       Date:  2019-07-08       Impact factor: 4.379

3.  Selective BET bromodomain inhibition as an antifungal therapeutic strategy.

Authors:  Flore Mietton; Elena Ferri; Morgane Champleboux; Ninon Zala; Danièle Maubon; Yingsheng Zhou; Mike Harbut; Didier Spittler; Cécile Garnaud; Marie Courçon; Murielle Chauvel; Christophe d'Enfert; Boris A Kashemirov; Mitchell Hull; Muriel Cornet; Charles E McKenna; Jérôme Govin; Carlo Petosa
Journal:  Nat Commun       Date:  2017-05-18       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.